BioChain Logo
 Sample Preparation for Diagnostics and Drug Discovery          ISO Certificate Order Online or Call 1-888-RNA-BLOT

   Help 

Search:

  Product Browser

  How to Order

Browse Online Catalog

  Your Account

  What's New

   New Products

   Promotions

   Company news
 
 
Endothelial Progenitor Cells

Features

¡ñ Primary cells    
¡ñ CD 133+ resuspension cells

¡ñ Progenitor cells, not terminally differentiated mature endothelial cells such as HUVEC and HMVEC  
¡ñ Capable of differentiating into specific subtypes of endothelial cells, change to CD 133- when attached to the cell culture vessel   
¡ñ Gene expression pattern is more similar to that of endothelial cells from tumors 

¡ñ Specifically migrate to tumors   
¡ñ Quantity and functions in the blood is altered during pathogenesis of a variety of diseases    

Applications
EPC is a unique primitive cell type and is involved in a variety of human diseases. Isolated EPC cells can be used in research and drug discovery in the following areas:
¡ñ Cancers such as lymphoma, breast cancer, lung cancer and inoperable heptocellular carcinoma (HCC)
¡ñ Vascular diseases such as coronary artery disease (CAD) and acute myocardial infarction
¡ñ Diabetes Mellitus
¡ñ Ischemia
¡ñ Pulmonary hypertension
¡ñ Cerebral vascular disease
¡ñ Arthritis
¡ñ Cutaneous wound healing and skin regeneration

 
   Human (Normal)  new

 

 

We're Listed On The Hayward Business List

A Verisign Secure Site
 


BioChain Institute, Inc. - 3517 Breakwater Avenue, Hayward, CA 94545, USA
- Tel: 888.762.2568 or 510.783.8588 - fax: 510.783.5386
e-mail: order@biochain.com website: www.biochain.com
All of our products are intended to be used for RESEARCH purposes only.
Copyright © 2004 All Rights Reserved.   Disclaimer   Security & Privacy